Search results for "guidelines"

showing 10 items of 617 documents

Linee guida in ortodonzia e attuale valutazione dei profili di responsabilità

2016

Alla luce della nuova legge entrata in vigore in Italia, si discute il valore protettivo delle linee guida in ortodonzia sotto il profilo medico-legale. OBJECTIVES. In view of the Italian law recently come into force, this study aims at discussing the protective value of orthodontic guidelines in terms of legal medicine. MATERIALS AND METHODS. A review of orthodontic guidelines was conducted, including general orthodontic guidelines as well as specific guidelines for clinical and surgical cases. RESULTS AND CONCLUSIONS. Orthodontic practices envisaging professional liability include diagnosis, prevention, interception, care planning and treatment of all types of malocclusion (even when asso…

guidelines; orthodonticsHealth careBest practice030206 dentistryGuideline03 medical and health sciences0302 clinical medicineSettore MED/28 - Malattie OdontostomatologicheProfessional liabilityLINEE GUIDA ORTODONZIA ASSISTENZA SANITARIA RESPONSABILITA' PROFESSIONALE CURE OTTIMALIOrthodonticBest practice; Guidelines; Health care; Orthodontics; Professional liability; Orthodontics; Oral Surgery030216 legal & forensic medicineOral Surgeryorthodontics
researchProduct

Review of carbon emissions offsetting guidelines using instructional criteria

2023

Abstract Purpose Carbon offsetting is one of the tools that companies can use to achieve their climate targets. The ability of a company to offset its emissions successfully depends on the availability and quality of guidance on the subject. This study explores how well existing offsetting guidelines equip corporations to achieve successful emissions offsetting. Methods Instructional criteria were developed and used to evaluate seven guidelines. The contents of each guideline were assessed based on how they instruct a company to achieve emissions offsetting that fulfills five criteria for appropriate offsetting: target affiliation, Paris compatibility, effectiveness, prioritizing removals, …

hiilidioksidiPariisin ilmastosopimusnet zerotoimintaohjeetoffsettingcarbon neutralitycarbon creditsSDG 8 - Decent Work and Economic GrowthGuidelines/dk/atira/pure/sustainabledevelopmentgoals/decent_work_and_economic_growthClimate targetsyrityksethiilineutraaliuskasvihuonekaasutilmastopolitiikka/dk/atira/pure/sustainabledevelopmentgoals/climate_actionSDG 13 - Climate ActionpäästökompensaatioGeneral Environmental ScienceInternational Journal of Life Cycle Assessment
researchProduct

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.

2012

Background Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. Methods We conducted a systematic review and critical assessment of the available evidence pertaining to the epidemiology, pathophysiology, diagnosis and management of hirsutism. Results The prevalence of hirsutism is ~10% in most populations, with the important exception of Far-East Asian women who present hirsutism less frequently. Although usually caused by relatively benign functional conditions, with the polycystic ovary syndrome leading the list of the most frequent etiologies, hirsutism may be th…

hirsutism; androgen excess; guidelinesmedicine.medical_specialtyPediatricsHirsutismMEDLINETerminal hairAndrogen ExcessSettore MED/13 - EndocrinologiaIntervention (counseling)EpidemiologyMedicineHumansguidelineshirsutismSocieties MedicalHirsutism PCOS Hyperandrogenism Adrenal hyperplasia idiopathic hirsutismGynecologybusiness.industryObstetrics and Gynecologymedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryReproductive Medicinehirsutism androgen excess terminal hair polycystic ovary syndrome guidelinesEtiologyAndrogensFemaleandrogen excessbusinessHair FolliclePolycystic Ovary SyndromeHuman reproduction update
researchProduct

Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch r…

2022

Abstract Objective To compare colorectal cancer (CRC) incidences in carriers of pathogenic variants of the MMR genes in the PLSD and IMRC cohorts, of which only the former included mandatory colonoscopy surveillance for all participants. Methods CRC incidences were calculated in an intervention group comprising a cohort of confirmed carriers of pathogenic or likely pathogenic variants in mismatch repair genes (path_MMR) followed prospectively by the Prospective Lynch Syndrome Database (PLSD). All had colonoscopy surveillance, with polypectomy when polyps were identified. Comparison was made with a retrospective cohort reported by the International Mismatch Repair Consortium (IMRC). This com…

koloskopiaEuropean Hereditary Tumour Group (EHTG) and the International Mismatch Repair Consortium (IMRC)Epidemiology3122 Cancersehkäisycolorectal cancerPenetrancesegregaatioläpäisevyyssuolistosyövätGUIDELINESover-diagnosisSDG 3 - Good Health and Well-beingpreventionTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]1112 Oncology and CarcinogenesisOncology & CarcinogenesispenetranceLynchin oireyhtymäEpidemiologiaSegregation analysisOver-diagnosiGenetics (clinical)segregation analysisScience & TechnologyIncidencePreventionColonoscòpiaGERMLINE MUTATIONSColonoscopyprospectiveCARRIERSColorectal cancer3142 Public health care science environmental and occupational healthProspectiveLynch syndromeOncologyLynch SyndromeOver-diagnosisincidence/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingCLINICAL MANAGEMENTilmaantuvuusLife Sciences & Biomedicine
researchProduct

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diab…

2017

Aims These recommendations aim to improve care for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk in Central and Eastern Europe. Cardiovascular disease (CVD) and/or chronic kidney disease (CKD) are major interdependent comorbidities in patients with T2D, accounting for 50% of mortality. Following recent CV outcomes trial (CVOT) results, including those from EMPA-REG OUTCOME®, LEADER®, SUSTAIN™-6 and, most recently, the CANVAS study, it is essential to develop regional expert consensus recommendations to aid physicians in interpreting these newest data to clinical practice. Methods The Central and Eastern European Diabetes Expert Group (CEEDEG) followed a Delphi method …

lcsh:Diseases of the circulatory (Cardiovascular) systemKeywords: Anti-glycaemic drugs ; Cardiovascular disease ; Renal disease ; Type 2 diabetesmedicine.medical_specialtyEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDelphi method610 Medicine & health030209 endocrinology & metabolismReviewType 2 diabetesDisease030204 cardiovascular system & hematologyAnti-glycaemic drugs2705 Cardiology and Cardiovascular MedicineTranslational Research BiomedicalRenal disease03 medical and health sciences0302 clinical medicineMultidisciplinary approachDiabetes mellitusDiabetes MellitusmedicineHumansHypoglycemic AgentsEurope EasternIntensive care medicineExpert TestimonyClinical Trials as Topicbusiness.industryType 2 diabetesCardiovascular diseasemedicine.diseaseExpert groupEuropeEastern european2712 Endocrinology Diabetes and MetabolismTreatment Outcome2724 Internal MedicineCardiovascular Diseaseslcsh:RC666-701Practice Guidelines as TopicCardiology and Cardiovascular MedicinebusinessKidney diseaseCardiovascular Diabetology
researchProduct

Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies

2018

Daratumumab has proven to be highly efficacious for relapsed and refractory multiple myeloma (MM) and has recently been approved in the frontline setting for MM patients ineligible for transplantation. In the future, expanded indications are possible for daratumumab and other anti-CD38 monoclonal antibodies in development. For several years, it has been recognized that these therapies interfere with blood bank testing by binding to CD38 on red blood cells and causing panagglutination on the Indirect Antiglobulin Test. This can lead to redundant testing and significant delays in patient care. Given the anticipated increase in utilization of anti-CD38 monoclonal antibodies, as well as the tra…

lcsh:Immunologic diseases. Allergymedicine.medical_specialtyErythrocytesBlood transfusionmedicine.drug_classmedicine.medical_treatmentImmunologyAntineoplastic AgentsReview030204 cardiovascular system & hematologyCD38Monoclonal antibody03 medical and health sciences0302 clinical medicinemedicineHumansImmunology and AllergyBlood TransfusionDiagnostic ErrorsIntensive care medicinetransfusionIsatuximabbusiness.industryAntibodies MonoclonalDaratumumabdaratumumabADP-ribosyl Cyclase 1TransplantationCoombs TestBlood Grouping and Crossmatchingmonoclonal antibodyPractice Guidelines as TopicIndirect Antiglobulin Testlcsh:RC581-607Multiple MyelomabusinessCD38Blood bankProtein Bindingisatuximab030215 immunologyFrontiers in Immunology
researchProduct

Improving quality and safety in nursing homes and home care: the study protocol of a mixed-methods research design to implement a leadership interven…

2018

IntroductionNursing homes and home care face challenges across different countries as people are living longer, often with chronic conditions. There is a lack of knowledge regarding implementation and impact of quality and safety interventions as most research evidence so far is generated in hospitals. Additionally, there is a lack of effective leadership tools for quality and safety improvement work in this context.Methods and analysisThe aim of the ‘Improving Quality and Safety in Primary Care—Implementing a Leadership Intervention in Nursing Homes and Homecare’ (SAFE-LEAD) study is to develop and evaluate a research-based leadership guide for managers to increase quality and safety compe…

leadershipAttitude of Health PersonneleducationPsychological interventionGuidelines as TopicNorwegiannursing homescontextprimary care03 medical and health sciencesPatient safety0302 clinical medicineNursingSurveys and QuestionnairesProtocolpatient safetyHumansMedicineSocial media15061704030212 general & internal medicineCompetence (human resources)interventionNetherlandspasientsikkerhetNorway:Medical disciplines: 700::Clinical medical disciplines: 750::Geriatrics: 778 [VDP]business.industry030503 health policy & servicesMultimethodologyaldershjemGeneral MedicineHome Care ServicesQuality Improvementlanguage.human_languageNursing HomesPeer reviewsykehjemResearch DesignqualitylanguageHealth Services Research0305 other medical scienceNursing homesbusinessProgram EvaluationBMJ Open
researchProduct

Creating a Framework for Improving the Learnability of a Complex System

2006

When designing complex systems, it is crucial but challenging to make them easy to learn. In this paper, a framework for improving the learnability of a complex system is presented. A classification of factors affecting the learnability of a building modeling system as well as guidelines that refine the factors into practical ways of action are introduced. The factors and guidelines include issues related to the user interface, conformity of the system to user’s expectations, and training. The classification is based on empirical research during which learnability was assessed with several methods. The methodology and the classification of learnability factors can be used as references when…

learnabilityease-of-learningguidelinescomplex systemsgrounded theory
researchProduct

Autophagy

2021

In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide…

macroautophagy;autophagyAutophagosome[SDV]Life Sciences [q-bio]canceLC3 macroautophagyautophagosomeneurodegeneration;[SDV.BC]Life Sciences [q-bio]/Cellular BiologyAutophagy AutophagosomeNOstress vacuolestressautophagic processesstrerfluxLC3cancerguidelinesAutophagosome; cancer; flux; LC3; lysosome; macroautophagy; neurodegeneration; phagophore; stress; vacuoleSettore BIO/06 - Anatomia Comparata E Citologia[SDV.BC] Life Sciences [q-bio]/Cellular BiologyComputingMilieux_MISCELLANEOUSMedaka oryzias latipesphagophorevacuoleQHneurodegenerationAutophagosome cancer flux LC3 lysosome macroautophagy neurodegeneration phagophore stress vacuoleautophagy; autophagic processes; guidelines; autophagosome; cancer; flux; LC3; lysosome; macroautophagy; neurodegeneration; phagophore; stress; vacuolefluxmacroautophagystress.lysosomeAutophagosome; LC3; cancer; flux; lysosome; macroautophagy; neurodegeneration; phagophore; stress; vacuoleSettore BIO/17 - ISTOLOGIARC
researchProduct

Robotic i.v. medication compounding: Recommendations from the international community of APOTECAchemo users.

2016

Purpose The development of recommendations for advancing automated i.v. medication compounding is described. Summary Managing the shift from manual to robotic compounding of i.v. therapies requires an awareness of how automation affects practice and how to best implement robotics into current practice. An international panel of pharmacy professionals, researchers, and technology leaders with experience in i.v. robotics collaborated during a two-day meeting in August 2014 to define a general set of principles to broaden the understanding of the fundamental elements of robotic compounding worldwide. Participants were divided into four working groups (technology and safety; drugs and products;…

media_common.quotation_subjectDrug CompoundingPharmacy030226 pharmacology & pharmacy03 medical and health sciencesAutomation0302 clinical medicineNursingSurveys and QuestionnairesMedicineHumansQuality (business)Set (psychology)media_commonPharmacologyDrug compoundingMedical educationbusiness.industryHealth PolicyInternational communityRoboticsCompoundingCurrent practice030220 oncology & carcinogenesisPractice Guidelines as TopicAdministration IntravenousWorking groupbusinessPharmacy Service HospitalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
researchProduct